Royalty Pharma Newsroom

Royalty Pharma Is Maintained at Buy by Citigroup

Dow JonesOct 26 02:38

Royalty Pharma Analyst Ratings

BenzingaOct 26 02:28

Morgan Stanley Maintains Royalty Pharma(RPRX.US) With Buy Rating, Raises Target Price to $51

Futu NewsOct 11 20:34

TD Cowen Maintains Royalty Pharma(RPRX.US) With Buy Rating, Maintains Target Price $42

Futu NewsOct 8 14:31

Goldman Sachs Maintains Royalty Pharma(RPRX.US) With Buy Rating, Maintains Target Price $51

Futu NewsSep 5 02:31

Royalty Pharma Analyst Ratings

BenzingaAug 14 19:15

Goldman Sachs Maintains Buy on Royalty Pharma, Raises Price Target to $51

BenzingaAug 14 19:14

Goldman Sachs Maintains Royalty Pharma(RPRX.US) With Buy Rating, Raises Target Price to $51

Futu NewsAug 13 22:32

Buy Rating Affirmed for Royalty Pharma Amidst Strong Financials and Positive Growth Outlook

TipRanksAug 13 21:47

Analysts Offer Insights on Healthcare Companies: CSL (OtherCMXHF) and Royalty Pharma (RPRX)

TipRanksAug 12 11:05

Analysts Are Bullish on These Healthcare Stocks: Royalty Pharma (RPRX), Arcellx Inc (ACLX)

TipRanksAug 9 21:53

Royalty Pharma (RPRX) Receives a Buy From Morgan Stanley

TipRanksAug 9 21:53

Royalty Pharma Analyst Ratings

BenzingaJul 12 01:17

Morgan Stanley Maintains Overweight on Royalty Pharma, Raises Price Target to $51

BenzingaJul 12 01:17

Morgan Stanley Sticks to Its Buy Rating for Royalty Pharma (RPRX)

TipRanksJul 11 20:49

UBS Downgrades Royalty Pharma to Neutral, Announces $28 Price Target

BenzingaJun 3 23:55

Royalty Pharma Analyst Ratings

BenzingaJun 3 23:50

Analysts Are Bullish on Top Healthcare Stocks: Merus (MRUS), Royalty Pharma (RPRX)

TipRanksMay 29 08:23

Royalty Pharma's Strategic Acquisitions and Compelling Valuation Warrant a Buy Rating

TipRanksMay 29 08:02

Bank of America Securities Keeps Their Buy Rating on Royalty Pharma (RPRX)

TipRanksMay 10 23:20